India's Data Protection Bill and What It Means For Alternative Data
On September 12, 2023, we hosted a client workshop titled "India's Data Protection Bill and What It Means For Alternative Data" which provides a thorough analysis of the evolving data privacy landscape in India. Below we provide the playback and highlight the key points discussed during the session.
Alternative Data for Tech Stock Analysis with Oxford Data Plan, PeerSpot, and Revelio Labs
On August 22nd, we were joined by Reyhan Ayas, Senior Economist at Revelio Labs, Josef Schmalfuss, Director at Oxford Data Plan, and Gershon Rossman, Director of Customer Success at PeerSpot to discuss the current tech landscape.
European Transaction Data Compliance Updates with Fable Data and Schulte Roth & Zabel
On August 15th, 2023, we were joined by Fable Data and Schulte Roth & Zabel to discuss the European transaction data landscape, in particular, the compliance challenges and best practices for vendors and buyers working with transaction data.
Quant and Fundamental Data Use Cases and Fresh Updates
On July 27th, 2023, we held an interactive data webinar where quant and fundamental data providers discussed use cases and fresh features. We had representatives from seven different vendors: aiQ, ETF Global, Fable Data, Macrobond, Nowcast, Pronto NLP, and SpiderRock.
Alternative Data and Emerging Markets Investing: Opportunities and Challenges
On July 25th, 2023, we were joined by Mysteel and Datago to discuss the potential of alternative data in shaping investment strategies, revealing hidden opportunities, and navigating potential challenges in emerging markets.
Alternative Data and Crypto Markets - Case Studies on Market Surveillance
On July 18th, we were joined by Kaiko, Stockpulse, and SRZ to discuss alternative data and regulations in the crypto markets. As cryptocurrencies and associated transactions continue to proliferate, understanding the role and utility of alternative data becomes imperative.
AI & Real World Data as a Strategic Opportunity for the Pharma Industry and Its Investors - Part 2
On June 28th, Alexandre Templier, President of Quinten AI, delivered a presentation on how his firm works with real-world clinical data. This is part two of the session titled “AI and Real-world Data as a Strategic Opportunity for the Pharma Industry.
AI & Pharmaceutical Legal Perspectives From The EU - Part 1
On June 28th, Christophe Fichet, Partner at Hughes Hubbard & Reed joined a client workshop discussing AI and real-world data as a strategic opportunity for the pharma industry.
H1 Legal and Compliance Wrap with Schulte Roth & Zabel
On this month’s legal and compliance workshop, Dallán Ryan, Data Strategy Content and Advisory Lead was joined by Schulte Roth & Zabel to review ChatGPT compliance, DTCC and data degradation, SEC exams, and web scraping updates.
How Level 3 Content Provides Users with Insights into Market Dynamics and Direction
On May 30th, Eagle Alpha hosted a workshop joined by BMLL, Kaiko, and Magma Capital Funds to discuss Level 3 order book data both in traditional capital markets as well as in cryptocurrency markets.
Location, Location, Location (Data) - A Compliance Discussion on Regulation, Data Provenance, and Ethics
On May 9th, 2023, we were joined by Ben Kozinn from Schulte Roth & Zabel, Kjartan Slette from Unacast, and Jason Sarfati from Gravy Analytics to discuss recent geolocation data collection and sharing developments.